RCEL · AVITA Medical, Inc. · Earnings Call Transcripts & Audio
$9.91
-0.28 (-2.74%)
At close · Sep 15
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's liquidity position and the Company's current forecast of operating results and cash flows, management determined there is substantial doubt about the Company's ability to continue as a going concern over the next twelve months following the date of issuance of these Consolidated Financial Statements due to the Company's debt repayment obligations, recurring losses, and historical negative cash flows.”View the 10-Q filed Aug 6, 2026
Market Cap
$305.56M
Shares
30.93M
AVITA Medical, Inc. Earnings Call Transcripts
Quarterly earnings calls for AVITA Medical, Inc. (RCEL), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Earnings call
FY26 · Q2
2026-08-06
AVITA Medical, Inc. (RCEL) Q2 2026 Earnings Call Transcript
Confident tone
Revenue growth and scale
Gross margin and operating leverage
2026 guidance raise
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-14
AVITA Medical, Inc. (RCEL) Q1 2026 Earnings Call Transcript
Positive tone
RECELL reimbursement recovery and demand normalization
Cohealyx commercial early adoption and clinical data
BARDA burn emergency preparedness contract
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-12
AVITA Medical, Inc. (RCEL) Q4 2025 Earnings Call Transcript
Positive tone
Product platform: ReCell, CoHiliX, PermeDerm
Utilization and account adoption
CoHiliX VAC committee reviews
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
AVITA Medical, Inc. (RCEL) Q3 2025 Earnings Call Transcript
Balanced tone
RECELL product and adoption
Reimbursement clarity and MAC rates
Cohealyx and PermeaDerm portfolio expansion
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
AVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call Transcript
Positive tone
Product portfolio expansion
OrbiMed credit facility amendment
Real-world evidence / clinical data
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript
Confident tone
Cohealyx Launch
RECELL GO mini Launch
Vitiligo Pause / Risk
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-07
AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript
Positive tone
Cohealyx dermal matrix
Revenue guidance and Q1 outlook
Clinical evidence and study enrollment
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
AVITA Medical, Inc. (RCEL) Q3 2024 Earnings Call Transcript
Confident tone
RECELL GO platform conversion
Cohealyx dermal matrix
Comprehensive treatment solution / ASP expansion
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
AVITA Medical, Inc. (RCEL) Q2 2024 Earnings Call Transcript
Positive tone
RECELL GO launch and capabilities
PermeaDerm adoption
VAC approval process and new accounts
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-11
AVITA Medical, Inc. (RCEL) Q1 2024 Earnings Call Transcript
Cautious tone
RECELL GO FDA review
Wound care portfolio expansion
Full-thickness skin defects launch
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-10
AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Call Transcript
Confident tone
RECELL GO PMA supplement and launch
Commercial revenue growth
Sales force expansion and new accounts
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
AVITA Medical, Inc. (RCEL) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
AVITA Medical, Inc. (RCEL) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-12
AVITA Medical, Inc. (RCEL) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
AVITA Medical, Inc. (RCEL) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-14
AVITA Medical, Inc. (RCEL) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-12
AVITA Medical, Inc. (RCEL) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-17
AVITA Medical, Inc. (RCEL) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-11
AVITA Medical, Inc. (RCEL) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
AVITA Medical, Inc. (RCEL) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-27
AVITA Medical, Inc. (RCEL) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-06-17
AVITA Medical, Inc. (RCEL) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-12
AVITA Medical, Inc. (RCEL) Q4 2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–23 of 23 earnings calls